SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Xcyte Therapies, Inc. (XCYT)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (5)6/22/2004 12:23:15 AM
From: mopgcw  Read Replies (1) of 16
 
cyte Therapies Rated New `Buy' at Wells Fargo :XCYT US
2004-04-26 08:57 (New York)

Princeton, New Jersey, April 26 (Bloomberg Data) -- Xcyte Therapies Inc.
(XCYT US) was rated new ``buy'' in new coverage by analyst Eun Yang at Wells
Fargo Securities. The price target is $10.00 per share.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News